How do low IgG levels, immune globulin therapy, and clinically isolated syndrome relate to multiple sclerosis?
The search results provided don't contain specific information about low IgG levels or immune globulin therapy in relation to clinically isolated syndrome (CIS) or MS. However, I can share what's known about CIS Show Full Answer
How do low IgG levels, immune globulin therapy, and clinically isolated syndrome relate to multiple sclerosis?
The search results provided don't contain specific information about low IgG levels or immune globulin therapy in relation to clinically isolated syndrome (CIS) or MS. However, I can share what's known about CIS itself.
CIS is a first episode of neurological symptoms lasting at least 24 hours, caused by inflammation and demyelination in the central nervous system. It's not MS yet, but it may progress to MS. About 60-80% of people with CIS who have brain lesions visible on MRI will develop MS over time.
Some disease-modifying therapies for MS can affect your immune system, which might impact immunoglobulin levels. If you're concerned about low IgG levels or considering immune globulin therapy, this is an important conversation to have with your neurologist. They can evaluate your specific situation, including your CIS diagnosis, MRI findings, and overall immune function to determine the best treatment approach.
Early treatment after CIS can help reduce inflammation and nerve damage, potentially improving long-term outcomes if MS develops.
April 21
Join
Your Privacy Choices
